KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Petmed Express (PETS) Net Margin (2016 - 2025)

Petmed Express' Net Margin history spans 16 years, with the latest figure at 25.95% for Q4 2025.

  • For Q4 2025, Net Margin fell 2453.0% year-over-year to 25.95%; the TTM value through Dec 2025 reached 34.7%, down 3483.0%, while the annual FY2025 figure was 2.76%, 4.0% down from the prior year.
  • Net Margin reached 25.95% in Q4 2025 per PETS's latest filing, down from 19.2% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 9.68% in Q3 2021 to a low of 66.73% in Q2 2025.
  • Average Net Margin over 5 years is 5.11%, with a median of 0.09% recorded in 2021.
  • Peak YoY movement for Net Margin: soared 710bps in 2024, then tumbled -7234bps in 2025.
  • A 5-year view of Net Margin shows it stood at 7.22% in 2021, then plummeted by -105bps to 0.37% in 2022, then plummeted by -767bps to 3.21% in 2023, then surged by 56bps to 1.43% in 2024, then plummeted by -1718bps to 25.95% in 2025.
  • Per Business Quant, the three most recent readings for PETS's Net Margin are 25.95% (Q4 2025), 19.2% (Q3 2025), and 66.73% (Q2 2025).